Lyell Immunopharma, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2020 | — | -3,289.5% | -3,228.2% |
| Sep 2020 | — | -3,443.3% | -3,338.2% |
| Mar 2021 | — | -2,264.6% | -2,251.2% |
| Jun 2021 | — | -2,386.1% | -2,381.8% |
| Sep 2021 | — | -1,784.4% | -1,774.0% |
| Mar 2022 | — | -12,400.7% | -12,322.6% |
| Jun 2022 | — | -104.3% | -101.6% |
| Sep 2022 | — | -2,214,566.7% | -2,341,800.0% |
| Mar 2023 | — | -96,240.0% | -103,013.8% |
| Jun 2023 | — | -244,092.6% | -236,629.6% |
| Sep 2023 | — | -236,156.0% | -203,412.0% |
| Mar 2024 | — | -1,852,500.0% | -2,022,233.3% |
| Jun 2024 | — | -396,369.2% | -352,376.9% |
| Sep 2024 | — | -148,544.1% | -131,126.5% |
| Mar 2025 | — | -819,528.6% | -745,642.9% |
| Jun 2025 | — | -589,250.0% | -533,550.0% |
| Sep 2025 | — | -248,353.3% | -258,973.3% |
| Mar 2026 | — | -2,213,050.0% | -1,207,650.0% |
| Jun 2026 | — | -1,183,425.0% | -1,118,875.0% |